QQQ   294.25 (+0.30%)
AAPL   148.70 (+0.45%)
MSFT   255.77 (+0.25%)
META   121.03 (+2.48%)
GOOGL   101.27 (+0.28%)
AMZN   95.49 (-1.09%)
TSLA   194.37 (-0.17%)
NVDA   172.33 (+1.83%)
NIO   12.12 (-5.16%)
BABA   86.42 (-1.30%)
AMD   77.56 (-0.09%)
T   19.17 (-0.57%)
MU   55.69 (-3.40%)
CGC   3.86 (+6.63%)
F   14.09 (+1.37%)
GE   85.45 (-0.60%)
DIS   98.71 (+0.86%)
AMC   8.46 (+17.01%)
PYPL   78.50 (+0.11%)
PFE   51.10 (+1.93%)
NFLX   318.93 (+4.39%)
QQQ   294.25 (+0.30%)
AAPL   148.70 (+0.45%)
MSFT   255.77 (+0.25%)
META   121.03 (+2.48%)
GOOGL   101.27 (+0.28%)
AMZN   95.49 (-1.09%)
TSLA   194.37 (-0.17%)
NVDA   172.33 (+1.83%)
NIO   12.12 (-5.16%)
BABA   86.42 (-1.30%)
AMD   77.56 (-0.09%)
T   19.17 (-0.57%)
MU   55.69 (-3.40%)
CGC   3.86 (+6.63%)
F   14.09 (+1.37%)
GE   85.45 (-0.60%)
DIS   98.71 (+0.86%)
AMC   8.46 (+17.01%)
PYPL   78.50 (+0.11%)
PFE   51.10 (+1.93%)
NFLX   318.93 (+4.39%)
QQQ   294.25 (+0.30%)
AAPL   148.70 (+0.45%)
MSFT   255.77 (+0.25%)
META   121.03 (+2.48%)
GOOGL   101.27 (+0.28%)
AMZN   95.49 (-1.09%)
TSLA   194.37 (-0.17%)
NVDA   172.33 (+1.83%)
NIO   12.12 (-5.16%)
BABA   86.42 (-1.30%)
AMD   77.56 (-0.09%)
T   19.17 (-0.57%)
MU   55.69 (-3.40%)
CGC   3.86 (+6.63%)
F   14.09 (+1.37%)
GE   85.45 (-0.60%)
DIS   98.71 (+0.86%)
AMC   8.46 (+17.01%)
PYPL   78.50 (+0.11%)
PFE   51.10 (+1.93%)
NFLX   318.93 (+4.39%)
QQQ   294.25 (+0.30%)
AAPL   148.70 (+0.45%)
MSFT   255.77 (+0.25%)
META   121.03 (+2.48%)
GOOGL   101.27 (+0.28%)
AMZN   95.49 (-1.09%)
TSLA   194.37 (-0.17%)
NVDA   172.33 (+1.83%)
NIO   12.12 (-5.16%)
BABA   86.42 (-1.30%)
AMD   77.56 (-0.09%)
T   19.17 (-0.57%)
MU   55.69 (-3.40%)
CGC   3.86 (+6.63%)
F   14.09 (+1.37%)
GE   85.45 (-0.60%)
DIS   98.71 (+0.86%)
AMC   8.46 (+17.01%)
PYPL   78.50 (+0.11%)
PFE   51.10 (+1.93%)
NFLX   318.93 (+4.39%)
NASDAQ:PRPO

Precipio - PRPO Stock Forecast, Price & News

$0.77
+0.01 (+0.87%)
(As of 12/1/2022 01:36 PM ET)
Add
Compare
Today's Range
$0.77
▼
$0.77
50-Day Range
$0.75
▼
$0.89
52-Week Range
$0.75
▼
$2.20
Volume
4 shs
Average Volume
28,739 shs
Market Capitalization
$17.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PRPO stock logo

About Precipio (NASDAQ:PRPO) Stock

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.

Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

PRPO Stock News Headlines

November 7, 2022 | finance.yahoo.com
Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference
November 2, 2022 | finance.yahoo.com
Precipio Announces Third Quarter Shareholder Update Call
October 18, 2022 | finance.yahoo.com
RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - Yahoo Finance
October 18, 2022 | finance.yahoo.com
Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future
October 7, 2022 | finance.yahoo.com
Medical Device and Diagnostic Reimbursements Expert Joins NDA Partners as Expert Consultant - Yahoo Finance
October 7, 2022 | benzinga.com
Precipio And 2 Other Penny Stocks Insiders Are Aggressively Buying - Liberty Star Uranium (OTC:LBSR), Cle - Benzinga
September 17, 2022 | finance.yahoo.com
Point of Care (PoC) Infectious Disease Testing Market Surging Over 4X Touching USD 4.22 Billion by 2028 | BlueWeave Consulting - Yahoo Finance
September 17, 2022 | globenewswire.com
Point of Care (PoC) Infectious Disease Testing Market Surging Over 4X Touching USD 4.22 Billion by 2028 | BlueWeave Consulting - GlobeNewswire
September 15, 2022 | globenewswire.com
Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen - GlobeNewswire
September 15, 2022 | finance.yahoo.com
Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™
September 1, 2022 | reuters.com
PRPO.OQ - Precipio Inc | Stock Price & Latest News | Reuters
August 25, 2022 | globenewswire.com
Sharon Robins Joins Precipio's Products Division as Senior - GlobeNewswire
August 24, 2022 | finance.yahoo.com
Sharon Robins Joins Precipio’s Products Division as Senior Director of Laboratory & Hospital Sales
August 16, 2022 | seekingalpha.com
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha
August 16, 2022 | globenewswire.com
Precipio Launches New 1-Step Technology for all HemeScreen Assays - GlobeNewswire
August 16, 2022 | finance.yahoo.com
Precipio Launches New 1-Step Technology for all HemeScreen Assays
August 10, 2022 | globenewswire.com
Toni-Ann Mills Joins Precipio's Products Division to Lead - GlobeNewswire
August 10, 2022 | finance.yahoo.com
Toni-Ann Mills Joins Precipio’s Products Division to Lead Channel Partner Training, Learning & Development
August 8, 2022 | benzinga.com
Precipio Announces Second Quarter Shareholder Update Call - Benzinga
August 8, 2022 | finance.yahoo.com
Precipio Announces Second Quarter Shareholder Update Call
August 7, 2022 | reuters.com
PRPO.O - Precipio Inc | Stock Price & Latest News | Reuters
July 21, 2022 | seekingalpha.com
Precipio to distribute HemeScreen through Fisher Healthcare channel - Seeking Alpha
July 20, 2022 | globenewswire.com
Precipio to distribute HemeScreen® through Fisher Healthcare channel - GlobeNewswire
July 20, 2022 | finance.yahoo.com
Precipio to distribute HemeScreen® through Fisher Healthcare channel
June 15, 2022 | finance.yahoo.com
Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote - Yahoo Finance
See More Headlines
Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

PRPO Company Calendar

Last Earnings
8/23/2018
Today
12/01/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/29/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRPO
CUSIP
N/A
CIK
1043961
Web
www.precipiodx.com
Phone
(203) 787-7888
Fax
402-452-5401
Employees
54
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,530,000.00
Net Margins
-128.09%
Pretax Margin
-127.93%
Return on Equity
-56.55%
Return on Assets
-44.89%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
1.68
Quick Ratio
1.53

Sales & Book Value

Annual Sales
$8.85 million
Price / Sales
1.98
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.80 per share
Price / Book
0.96

Miscellaneous

Outstanding Shares
22,820,000
Free Float
20,880,000
Market Cap
$17.50 million
Optionable
Not Optionable
Beta
2.10

Key Executives

  • Mr. Ilan DanieliMr. Ilan Danieli (Age 50)
    Founder, Pres, CEO & Director
    Comp: $480.96k
  • Mr. Ahmed Zaki SabetMr. Ahmed Zaki Sabet (Age 35)
    Chief Operating Officer
    Comp: $229.03k
  • Dr. Ayman Mohamed M.D. (Age 37)
    Chief Technology Officer
    Comp: $254.5k
  • Mr. Matthew Gage (Age 55)
    Interim Chief Financial Officer
  • Ms. Miri Chiko-Radomski
    Chief Legal Counsel & People Officer
  • Mr. Keith Meadors
    Sr. VP of Products Division

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













PRPO Stock - Frequently Asked Questions

How have PRPO shares performed in 2022?

Precipio's stock was trading at $1.58 on January 1st, 2022. Since then, PRPO stock has decreased by 51.5% and is now trading at $0.7668.
View the best growth stocks for 2022 here.

When is Precipio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023.
View our PRPO earnings forecast.

How were Precipio's earnings last quarter?

Precipio, Inc. (NASDAQ:PRPO) issued its quarterly earnings results on Thursday, August, 23rd. The biotechnology company reported ($0.15) EPS for the quarter, missing the consensus estimate of $1.93 by $2.08. The biotechnology company had revenue of $0.82 million for the quarter. Precipio had a negative trailing twelve-month return on equity of 56.55% and a negative net margin of 128.09%.

When did Precipio's stock split?

Shares of Precipio reverse split before market open on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Precipio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Inpixon (INPX) and Jaguar Health (JAGX).

What is Precipio's stock symbol?

Precipio trades on the NASDAQ under the ticker symbol "PRPO."

How do I buy shares of Precipio?

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Precipio's stock price today?

One share of PRPO stock can currently be purchased for approximately $0.77.

How much money does Precipio make?

Precipio (NASDAQ:PRPO) has a market capitalization of $17.50 million and generates $8.85 million in revenue each year. The biotechnology company earns $-8,530,000.00 in net income (profit) each year or ($0.52) on an earnings per share basis.

How can I contact Precipio?

Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The official website for the company is www.precipiodx.com. The biotechnology company can be reached via phone at (203) 787-7888, via email at investors@precipiodx.com, or via fax at 402-452-5401.

This page (NASDAQ:PRPO) was last updated on 12/1/2022 by MarketBeat.com Staff